GNH USA

Europe — EMA

Montelukast Sandoz

GNH USA supplies Montelukast Sandoz (Montelukast), a leukotriene receptor antagonist for asthma and allergic rhinitis. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Montelukast Sandoz, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.

GNH USA supplies Montelukast Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Montelukast used for?

Montelukast acts on the leukotriene pathway to control chronic respiratory conditions.

Asthma (maintenance therapy): Reduces the frequency of asthma attacks and improves lung function. Allergic rhinitis: Alleviates nasal congestion, sneezing and itching associated with seasonal allergies. Exercise‑induced bronchoconstriction: Prevents narrowing of the airways triggered by physical activity.

What are the side effects of Montelukast?

Montelukast may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Cough: transient irritation. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis. - Neuropsychiatric events: agitation, depression, suicidal thoughts. - Hepatic injury: rare cases of elevated liver enzymes or hepatitis.

What precautions apply to Montelukast?

Montelukast requires careful consideration in several clinical situations.

Pregnancy: Use only if clearly needed, as safety data are limited. Breastfeeding: Caution, drug may be excreted in milk. Liver impairment: Monitor liver function; dosage adjustment may be required. Concomitant enzyme inducers (e.g., phenobarbital, rifampin): May reduce effectiveness. Store at ambient temperature: Keep below 25 °C, retain original packaging and protect from moisture.

What does Montelukast interact with?

Montelukast can interact with other medicines that affect its metabolism or therapeutic outcomes.

Major Interactions (Avoid): - Phenobarbital, carbamazepine, rifampin: Induce metabolism, decreasing drug levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): May increase exposure.

Moderate Interactions (Monitor Closely): - Warfarin: May enhance anticoagulant effect; monitor INR. - Theophylline: Potential alteration of plasma concentrations. - Beta‑agonists: No direct interaction, but monitor overall asthma control.

Frequently asked questions

What is Montelukast Sandoz used for?+
Montelukast Sandoz is prescribed for the maintenance treatment of asthma, to relieve symptoms of allergic rhinitis, and to prevent exercise‑induced bronchoconstriction. It helps reduce airway inflammation and improves breathing in patients with these chronic respiratory conditions.
How does Montelukast work?+
Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This prevents leukotriene D4 from binding, which in turn reduces bronchoconstriction, mucus production, and inflammatory cell recruitment in the airways, leading to better respiratory function.
What is the usual dose of Montelukast?+
The appropriate dose of Montelukast is determined by a qualified prescriber based on the patient’s age, condition, and clinical response. Healthcare professionals follow approved labeling and individual patient needs when setting the regimen.
Is Montelukast safe in pregnancy or breastfeeding?+
Safety data for Montelukast during pregnancy are limited, so it should only be used when the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding because the drug can be excreted in breast milk.
How do I order Montelukast Sandoz from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Montelukast compare with other asthma treatments?+
Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is especially useful for patients with aspirin‑exacerbated respiratory disease or those who prefer a non‑inhaled option, though it is generally used as add‑on therapy rather than a sole replacement.
How should Montelukast be stored and handled?+
Montelukast tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.
How is Montelukast administered?+
Montelukast is taken orally, usually as a tablet swallowed whole with water. It can be taken with or without food, and the dose is typically taken once daily at the same time each day for consistent blood levels.
What are the most serious risks to watch for while taking Montelukast?+
Serious risks include neuropsychiatric events such as agitation, depression, or suicidal thoughts, as well as severe allergic reactions like rash, angioedema, or anaphylaxis. Rare hepatic injury may also occur, so any signs of liver dysfunction should be reported promptly.
Who should not use Montelukast?+
Montelukast should not be used by individuals with a known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe liver impairment, and it is generally avoided in patients where alternative therapies are more appropriate based on clinical judgment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
Sandoz A/S
Origin
EU

Related products